Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MTX-101 by Mozart Therapeutics for Celiac Disease: Likelihood of Approval
MTX-101 is under clinical development by Mozart Therapeutics and currently in Phase I for Celiac Disease. According to GlobalData, Phase...
Data Insights
MTX-101 by Mozart Therapeutics for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
MTX-101 is under clinical development by Mozart Therapeutics and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes). According...